Martingale Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-9,808
Closed -$346K 949
2015
Q1
$346K Buy
+9,808
New +$332K 0.01% 762

Other funds holding BRLI

Martingale Asset Management's BRLI Position: Q2 2015 in Review

Martingale Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 9,808 shares — an estimated $346K sold.

Martingale Asset Management first reported a position in BRLI in Q1 2015 and held it in 1 quarter. The position peaked at $346K in Q1 2015. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

  • Martingale Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
  • Martingale Asset Management sold 9,808 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $346K.
  • Martingale Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q1 2015 and held it in 1 quarter.
  • Martingale Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $346K in Q1 2015.
  • 183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Martingale Asset Management's 13F filing for Q2 2015, filed 12 Aug 2015.